{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:35:08Z","timestamp":1791077708883,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173687"],"award-info":[{"award-number":["82173687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC1902089"],"award-info":[{"award-number":["XLYC1902089"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115076","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T12:24:34Z","timestamp":1673353474000},"page":"115076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Optimization of BAX trigger site activator BTSA1 with improved antitumor potency and in vitro ADMET properties"],"prefix":"10.1016","volume":"248","author":[{"given":"Zhenwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2022.115076_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115076_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"issue":"6009","key":"10.1016\/j.ejmech.2022.115076_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1190217","article-title":"BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program","volume":"330","author":"Ren","year":"2010","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115076_bib4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ncb3236","article-title":"An interconnected hierarchical model of cell death regulation by the BCL-2 family","volume":"17","author":"Chen","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115076_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2010.10.019","article-title":"BH3-triggered structural reorganization drives the activation of proapoptotic BAX","volume":"40","author":"Gavathiotis","year":"2010","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.ejmech.2022.115076_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41589-019-0306-6","article-title":"Targeting BAX to drug death directly","volume":"15","author":"Walensky","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115076_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2022.115076_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.115076_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114184","article-title":"Trends in targeting Bcl-2 anti-apoptotic proteins for cancer treatment","volume":"232","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"269","key":"10.1016\/j.ejmech.2022.115076_bib10","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115076_bib11","first-page":"1070","article-title":"Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases","volume":"9","author":"Milas","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115076_bib12","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1007\/s11033-012-1500-8","article-title":"Expressions of GRP78 and Bax associate with differentiation, metastasis, and apoptosis in non-small cell lung cancer","volume":"39","author":"Sun","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115076_bib13","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1074\/jbc.M500084200","article-title":"Nicotine inactivation of the proapoptotic function of Bax through phosphorylation","volume":"280","author":"Xin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.ejmech.2022.115076_bib14","doi-asserted-by":"crossref","first-page":"18859","DOI":"10.1074\/jbc.M512543200","article-title":"Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation","volume":"281","author":"Xin","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115076_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.2002.20.3.811","article-title":"Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer","volume":"20","author":"Jansson","year":"2002","journal-title":"J. Clin. Oncol. : off. j. Am. Soc. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115076_bib16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI118715","article-title":"Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice","volume":"97","author":"Bargou","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115076_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115076_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nchembio.995","article-title":"Direct and selective small-molecule activation of proapoptotic BAX","volume":"8","author":"Gavathiotis","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115076_bib19","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/jm501123r","article-title":"Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents","volume":"58","author":"Stornaiuolo","year":"2015","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115076_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2017.09.001","article-title":"Direct activation of BAX by BTSA1 overcomes apoptosis resistance in acute myeloid leukemia","volume":"32","author":"Reyna","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2022.115076_bib21","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1038\/ncomms5935","article-title":"Small-molecule Bax agonists for cancer therapy","volume":"5","author":"Xin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.115076_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113427","article-title":"Further lead optimization on Bax activators: design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer","volume":"219","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115076_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejmech.2019.06.004","article-title":"Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer","volume":"178","author":"Liu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115076_bib24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/MCB.00996-13","article-title":"Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis","volume":"34","author":"Zhao","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.ejmech.2022.115076_bib25","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1021\/acs.jmedchem.0c01454","article-title":"HDAC-bax multiple ligands enhance bax-dependent apoptosis in HeLa cells","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115076_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115076_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/med.21379","article-title":"Direct activation of bax protein for cancer therapy","volume":"36","author":"Liu","year":"2016","journal-title":"Med. Res. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:26Z","timestamp":1759330166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"alternative-id":["S0223523422009783"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115076","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of BAX trigger site activator BTSA1 with improved antitumor potency and in vitro ADMET properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115076"}}